Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00652210 · ClinicalTrials.gov registry record · Phase 1
Use of Multiphoton Microscopy in the Diagnosis of Cancer
A Phase 1 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 1
- Development phase
- 344
- Enrollment target
NCT00652210: Completed Phase 1 study, sponsored by Weill Medical College of Cornell University.
NCT00652210 is a Phase 1 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 344 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (473% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00652210, a Phase 1 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 344 participants
- Enrollment target
Study Summary
Multiphoton microscopy (MPM) has been shown to be able to image tissue at a cellular level. Our project will initially evaluated the ability of MPM imaging to distinguish normal bladder urothelium from atypical and malignant urothelium in the ex vivo setting. After development of sufficient criteria, we plan to develop an endoscopic bladder probe that will provide a non-invasive means to image the interior of the bladder at the cellular level, which would provide direct evidence of the presence of tumor without a biopsy. After exhibiting usefulness of MPM imaging for bladder cancer, we will look at other organs beginning with the colon.
Interventions
- OTHER Multiphoton microscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2005-06 |
| Est. Completion | 2015-09 |
| Phase | Phase 1 |
What the finished NCT00652210 record still lists
NCT00652210 is an interventional study that assigns participants to a tested intervention. The registered 344 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (473% higher).
The record links to 0 conditions, and to 1 intervention - of which Multiphoton microscopy is the first listed.
NCT00652210 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00652210 about?
NCT00652210 is a clinical study titled "Use of Multiphoton Microscopy in the Diagnosis of Cancer". Multiphoton microscopy (MPM) has been shown to be able to image tissue at a cellular level. Our project will initially evaluated the ability of MPM imaging to distinguish normal bladder urothelium from atypical and malignant urothelium in the ex vivo setting. After development of sufficient criteria...
What is the current status of trial NCT00652210?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 344 participants. The study started on 2005-06. Estimated completion is 2015-09.
What interventions are being tested in trial NCT00652210?
The interventions under investigation include: Multiphoton microscopy (OTHER).
Who is sponsoring clinical trial NCT00652210?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00652210's enrollment target sits among peer trials
344 102nd of 2000 higher than 1,898 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06733363 · 344 participants · Phase 2
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- NCT07179380 · 344 participants · Phase 3
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- NCT07304024 · 344 participants · Phase 1
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
- NCT03972657 · 345 participants · Phase 1
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia